ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA: UN EPIFENOMENO?

Translated title of the contribution: Anticardiolipin antibodies (ACA) in multiple sclerosis: An epiphenomenon?

R. P. Cioffi, N. Giuliani, M. Margaglione, E. Grandone, G. Cappucci, P. Simone, P. A. Tonali

Research output: Contribution to journalArticle

Abstract

A significantly higher prevalence of generally low titers of serum autoantibodies is commonly found in multiple sclerosis (MS) patients compared to normal controls, even if no autoimmune diseases are associated. These antibodies are directed against antigens of either nervous tissue or other tissues. Their increased frequency probably reflects an alteration of mechanisms controlling B-cells activity. Anticardiolipin antibodies (ACA) are autoantibodies directed against anionic phospholipids. They play a pathogenetic role in a syndrome characterized by an increased risk of thrombotic events and also of ischemic strokes (antiphospholipid antibody syndrome). ACA have been found in MS patients. The purpose of this study was to compare the frequency of ACA and other autoantibodies in MS patients. ACA serum titers and lupus anticoagulant activity (LA) were measured in 37 patients with MS and 67 healthy controls (age and sex matched). In the MS group the presence of antinuclear (ANA), parietal cell (APCA), smooth muscle (ASMA), and mitochondrial (AMA) autoantibodies was also checked. ACA titers higher than normal values were found in 18,9% of MS patients, Control subjects had all normal ACA values. Among other autoantibodies, only ASMA showed high frequency (24,3%). Difference between ACA and ASMA frequencies was not significant (chi-square test). LA was always normal also in patients who presented high ACA titers. As it has been hypothesized for other autoantibodies, ACA probably do not play a pathogenetic role in MS. Their presence could represent the consequence of nonspecific B-cells overactivity.

Original languageItalian
Pages (from-to)775-778
Number of pages4
JournalRivista di Neurobiologia
Volume41
Issue number5
Publication statusPublished - 1995

Fingerprint

Anticardiolipin Antibodies
Multiple Sclerosis
Autoantibodies
Lupus Coagulation Inhibitor
B-Lymphocytes
Nerve Tissue
Antiphospholipid Syndrome
Chi-Square Distribution
Serum
Autoimmune Diseases
Smooth Muscle Myocytes
Phospholipids
Reference Values
Stroke
Antigens
Antibodies

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Cioffi, R. P., Giuliani, N., Margaglione, M., Grandone, E., Cappucci, G., Simone, P., & Tonali, P. A. (1995). ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA: UN EPIFENOMENO? Rivista di Neurobiologia, 41(5), 775-778.

ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA : UN EPIFENOMENO? / Cioffi, R. P.; Giuliani, N.; Margaglione, M.; Grandone, E.; Cappucci, G.; Simone, P.; Tonali, P. A.

In: Rivista di Neurobiologia, Vol. 41, No. 5, 1995, p. 775-778.

Research output: Contribution to journalArticle

Cioffi, RP, Giuliani, N, Margaglione, M, Grandone, E, Cappucci, G, Simone, P & Tonali, PA 1995, 'ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA: UN EPIFENOMENO?', Rivista di Neurobiologia, vol. 41, no. 5, pp. 775-778.
Cioffi RP, Giuliani N, Margaglione M, Grandone E, Cappucci G, Simone P et al. ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA: UN EPIFENOMENO? Rivista di Neurobiologia. 1995;41(5):775-778.
Cioffi, R. P. ; Giuliani, N. ; Margaglione, M. ; Grandone, E. ; Cappucci, G. ; Simone, P. ; Tonali, P. A. / ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA : UN EPIFENOMENO?. In: Rivista di Neurobiologia. 1995 ; Vol. 41, No. 5. pp. 775-778.
@article{dc33489335d04c2f81aeb9a64a380980,
title = "ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA: UN EPIFENOMENO?",
abstract = "A significantly higher prevalence of generally low titers of serum autoantibodies is commonly found in multiple sclerosis (MS) patients compared to normal controls, even if no autoimmune diseases are associated. These antibodies are directed against antigens of either nervous tissue or other tissues. Their increased frequency probably reflects an alteration of mechanisms controlling B-cells activity. Anticardiolipin antibodies (ACA) are autoantibodies directed against anionic phospholipids. They play a pathogenetic role in a syndrome characterized by an increased risk of thrombotic events and also of ischemic strokes (antiphospholipid antibody syndrome). ACA have been found in MS patients. The purpose of this study was to compare the frequency of ACA and other autoantibodies in MS patients. ACA serum titers and lupus anticoagulant activity (LA) were measured in 37 patients with MS and 67 healthy controls (age and sex matched). In the MS group the presence of antinuclear (ANA), parietal cell (APCA), smooth muscle (ASMA), and mitochondrial (AMA) autoantibodies was also checked. ACA titers higher than normal values were found in 18,9{\%} of MS patients, Control subjects had all normal ACA values. Among other autoantibodies, only ASMA showed high frequency (24,3{\%}). Difference between ACA and ASMA frequencies was not significant (chi-square test). LA was always normal also in patients who presented high ACA titers. As it has been hypothesized for other autoantibodies, ACA probably do not play a pathogenetic role in MS. Their presence could represent the consequence of nonspecific B-cells overactivity.",
keywords = "anticardiolipin antibodies, autoimmunity, multiple sclerosis",
author = "Cioffi, {R. P.} and N. Giuliani and M. Margaglione and E. Grandone and G. Cappucci and P. Simone and Tonali, {P. A.}",
year = "1995",
language = "Italian",
volume = "41",
pages = "775--778",
journal = "Rivista Italiana di Neurobiologia",
issn = "0035-6336",
publisher = "Editrice Pisani s.a.s.",
number = "5",

}

TY - JOUR

T1 - ANTICORPI ANTICARDIOLIPINA (ACA) NELLA SCLEROSI MULTIPLA

T2 - UN EPIFENOMENO?

AU - Cioffi, R. P.

AU - Giuliani, N.

AU - Margaglione, M.

AU - Grandone, E.

AU - Cappucci, G.

AU - Simone, P.

AU - Tonali, P. A.

PY - 1995

Y1 - 1995

N2 - A significantly higher prevalence of generally low titers of serum autoantibodies is commonly found in multiple sclerosis (MS) patients compared to normal controls, even if no autoimmune diseases are associated. These antibodies are directed against antigens of either nervous tissue or other tissues. Their increased frequency probably reflects an alteration of mechanisms controlling B-cells activity. Anticardiolipin antibodies (ACA) are autoantibodies directed against anionic phospholipids. They play a pathogenetic role in a syndrome characterized by an increased risk of thrombotic events and also of ischemic strokes (antiphospholipid antibody syndrome). ACA have been found in MS patients. The purpose of this study was to compare the frequency of ACA and other autoantibodies in MS patients. ACA serum titers and lupus anticoagulant activity (LA) were measured in 37 patients with MS and 67 healthy controls (age and sex matched). In the MS group the presence of antinuclear (ANA), parietal cell (APCA), smooth muscle (ASMA), and mitochondrial (AMA) autoantibodies was also checked. ACA titers higher than normal values were found in 18,9% of MS patients, Control subjects had all normal ACA values. Among other autoantibodies, only ASMA showed high frequency (24,3%). Difference between ACA and ASMA frequencies was not significant (chi-square test). LA was always normal also in patients who presented high ACA titers. As it has been hypothesized for other autoantibodies, ACA probably do not play a pathogenetic role in MS. Their presence could represent the consequence of nonspecific B-cells overactivity.

AB - A significantly higher prevalence of generally low titers of serum autoantibodies is commonly found in multiple sclerosis (MS) patients compared to normal controls, even if no autoimmune diseases are associated. These antibodies are directed against antigens of either nervous tissue or other tissues. Their increased frequency probably reflects an alteration of mechanisms controlling B-cells activity. Anticardiolipin antibodies (ACA) are autoantibodies directed against anionic phospholipids. They play a pathogenetic role in a syndrome characterized by an increased risk of thrombotic events and also of ischemic strokes (antiphospholipid antibody syndrome). ACA have been found in MS patients. The purpose of this study was to compare the frequency of ACA and other autoantibodies in MS patients. ACA serum titers and lupus anticoagulant activity (LA) were measured in 37 patients with MS and 67 healthy controls (age and sex matched). In the MS group the presence of antinuclear (ANA), parietal cell (APCA), smooth muscle (ASMA), and mitochondrial (AMA) autoantibodies was also checked. ACA titers higher than normal values were found in 18,9% of MS patients, Control subjects had all normal ACA values. Among other autoantibodies, only ASMA showed high frequency (24,3%). Difference between ACA and ASMA frequencies was not significant (chi-square test). LA was always normal also in patients who presented high ACA titers. As it has been hypothesized for other autoantibodies, ACA probably do not play a pathogenetic role in MS. Their presence could represent the consequence of nonspecific B-cells overactivity.

KW - anticardiolipin antibodies

KW - autoimmunity

KW - multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0029553555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029553555&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0029553555

VL - 41

SP - 775

EP - 778

JO - Rivista Italiana di Neurobiologia

JF - Rivista Italiana di Neurobiologia

SN - 0035-6336

IS - 5

ER -